These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10627288)

  • 1. Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ.
    Chang Z; Meyer K; Rapraeger AC; Friedl A
    FASEB J; 2000 Jan; 14(1):137-44. PubMed ID: 10627288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas.
    Mundhenke C; Meyer K; Drew S; Friedl A
    Am J Pathol; 2002 Jan; 160(1):185-94. PubMed ID: 11786412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition.
    Allen BL; Filla MS; Rapraeger AC
    J Cell Biol; 2001 Nov; 155(5):845-58. PubMed ID: 11724824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarities and differences between the effects of heparin and glypican-1 on the bioactivity of acidic fibroblast growth factor and the keratinocyte growth factor.
    Berman B; Ostrovsky O; Shlissel M; Lang T; Regan D; Vlodavsky I; Ishai-Michaeli R; Ron D
    J Biol Chem; 1999 Dec; 274(51):36132-8. PubMed ID: 10593896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues.
    Friedl A; Chang Z; Tierney A; Rapraeger AC
    Am J Pathol; 1997 Apr; 150(4):1443-55. PubMed ID: 9094999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukemia cell lines bind basic fibroblast growth factor (FGF) on FGF receptors and heparan sulfates: downmodulation of FGF receptors by phorbol ester.
    Liuzzo JP; Moscatelli D
    Blood; 1996 Jan; 87(1):245-55. PubMed ID: 8547648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor.
    Brown KJ; Parish CR
    Biochemistry; 1994 Nov; 33(46):13918-27. PubMed ID: 7524669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfate proteoglycan modulates keratinocyte growth factor signaling through interaction with both ligand and receptor.
    LaRochelle WJ; Sakaguchi K; Atabey N; Cheon HG; Takagi Y; Kinaia T; Day RM; Miki T; Burgess WH; Bottaro DP
    Biochemistry; 1999 Feb; 38(6):1765-71. PubMed ID: 10026256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
    Brown KJ; Hendry IA; Parish CR
    J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulphate proteoglycan in scleromyxedema promotes FGF-2 activity.
    Warner TF; Wrone DA; Williams EC; Cripps DJ; Mundhenke C; Friedl A
    Pathol Res Pract; 2002; 198(10):701-7. PubMed ID: 12498227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
    Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
    Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor (FGF)-2 mediates cell attachment through interactions with two FGF receptor-1 isoforms and extracellular matrix or cell-associated heparan sulfate proteoglycans.
    Richard C; Roghani M; Moscatelli D
    Biochem Biophys Res Commun; 2000 Sep; 276(2):399-405. PubMed ID: 11027487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity.
    Filla MS; Dam P; Rapraeger AC
    J Cell Physiol; 1998 Mar; 174(3):310-21. PubMed ID: 9462693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate proteoglycans as transducers of FGF-2 signalling.
    Quarto N; Amalric F
    J Cell Sci; 1994 Nov; 107 ( Pt 11)():3201-12. PubMed ID: 7699017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-surface heparan sulfate proteoglycans are essential components of the unconventional export machinery of FGF-2.
    Zehe C; Engling A; Wegehingel S; Schäfer T; Nickel W
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15479-84. PubMed ID: 17030799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action.
    Jones M; Tussey L; Athanasou N; Jackson DG
    J Biol Chem; 2000 Mar; 275(11):7964-74. PubMed ID: 10713114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.
    Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR
    Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rerouting of fibroblast growth factor 2 to the classical secretory pathway results in post-translational modifications that block binding to heparan sulfate proteoglycans.
    Wegehingel S; Zehe C; Nickel W
    FEBS Lett; 2008 Jul; 582(16):2387-92. PubMed ID: 18538671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.